A nasal spray for bulimia? Opiant enters Phase 2 trials
The age-old drug naloxone has undergone a resurgence in recent years as a tool for reversing opioid overdoses. Could it also help control other addictive disorders, such as bulimia nervosa?
The age-old drug naloxone has undergone a resurgence in recent years as a tool for reversing opioid overdoses. Could it also help control other addictive disorders, such as bulimia nervosa?
Now is not the time for celebration, but at least the crusade against opioid abuse registered a win in Trump's 2018 budget proposal.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
In February of this year, the FDA approved the Narcan nasal spray to revive patients that had overdosed on opioid drugs. But the real story of 2016 was how widely that antidote was needed. The epidemic reached all corners of America in deadly new synthetic forms, raising unprecedented awareness about the dangers of opioid use -- without yet bringing the death toll down.